Can Metformin Lower Need for Joint Replacement in Diabetes?

Patients with type 2 diabetes who were treated with metformin had a 30% reduction in risk for total knee and total hip replacement, compared with patients who did not receive the drug.

Related Keywords

Guangzhou , Guangdong , China , Changhai , Liaoning , Australia , Taiwan , Boston University , Massachusetts , United States , Texas , Boston , Houston , Jilin , Canada , Baylor College Of Medicine , Canadian , Davidt Felson , , Menzies Institute For Medical Research , National Natural Science Foundation Of China , University Of Tasmania , Taiwan National Health Insurance Research Database , Canadian Medical Association Journal , Wu Jieping Medical Foundation Program , Research Foundation , Technology Program , Changhai Ding , Menzies Institute , Medical Research , Canadian Medical Association , Medscape Medical , Baylor College , National Natural Science Foundation , Guangzhou Science , Guangdong Basic , Applied Basic Research Foundation , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Arthroplasty , Osteoarthritis Oa , Steoarthritis Generalized , A Osteoarthritis , Egenerative Joint Disease Djd , Rthritis Degenerative , Eneralized Osteoarthritis , Degenerative Arthritis , Total Hip Arthroplasty Tha , Total Hip Arthroplasty , Total Hip Replacement , Hip Replacement , Joint Replacement , Clinical Research , Clinic ,